Financhill
Back

Cardiff Oncology Quote, Financials, Valuation and Earnings

Sell
45

CRDF
Cardiff Oncology

Last Price:
3.64
Seasonality Move:
40.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Cardiff Oncology Price Quote

$3.64
+0.01 (+-2.67%)
(Updated: May 18, 2024 at 5:40 AM ET)

Cardiff Oncology Key Stats

Sell
45
Cardiff Oncology (CRDF) is a Sell

Day range:
$3.60 - $3.84
52-week range:
$0.94 - $6.42
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
265.87
P/B ratio:
2.67%

Volume:
516.6K
Avg. volume:
788.5K
1-year change:
105.08%
Market cap:
$162.4M
Revenue:
$488K
EPS:
$-0.9

How Much Does Cardiff Oncology Make?

Is Cardiff Oncology Growing As A Company?

  • What Is Cardiff Oncology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.47%
  • What Is Cardiff Oncology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cardiff Oncology Stock Price Performance

  • Did Cardiff Oncology Stock Go Up Last Month?
    Cardiff Oncology share price went down by -19.33% last month
  • Did CRDF's Share Price Rise Over The Last Year?
    CRDF share price rose by 105.08% over the past 1 year

What Is Cardiff Oncology 52-Week High & Low?

Cardiff Oncology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cardiff Oncology?

  • How Much Debt Does Cardiff Oncology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cardiff Oncology Have?
    Cash and short term investments quarterly total is $67.2M
  • What Is Cardiff Oncology’s Book Value Per Share?
    Book value per share is 1.36

Is Cardiff Oncology Cash Flow Positive?

  • What Is CRDF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$30M
  • What Is Cardiff Oncology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $107K
  • What Is Cardiff Oncology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $33.5M

Cardiff Oncology Return On Invested Capital

  • Is Management Doing A Good Job?
    CRDF return on invested capital is -51.37%
  • What Is Cardiff Oncology Return On Assets?
    ROA measures how assets are converting to revenues and is -44.89%
  • What Is CRDF Return On Equity?
    ROE is a measure of profitability and is -51.37%

Cardiff Oncology Earnings Date & Stock Price

Cardiff Oncology Competitors

  • Who Are Cardiff Oncology's Competitors?
    Below is a list of companies who compete with Cardiff Oncology or are related in some way:
    • Adial Pharmaceuticals Inc (ADIL)
    • Biolase Inc (BIOL)
    • BioVie Inc (BIVI)
    • Perspective Therapeutics Inc (CATX)
    • Tenon Medical Inc (TNON)

Cardiff Oncology Dividend Yield

Data Unavailable

Cardiff Oncology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 10.81%
Revenue: 146.99% 272.73%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.83
Upside from Last Price: 170.89%

Major Shareholders

  • How many CRDF shares are owned by institutional investors?
    7.7M CRDF shares are owned by institutional investors
  • How many CRDF shares are owned by insiders?
    1.9M CRDF shares are owned by insiders